Clinical Trial: Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931626) titled 'Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer' on April 04.

Brief Summary: This is an open-label study of NMS-03305293 with Temozolomide (TMZ) in patients with Small Cell Lung Cancer (SCLC). The aim of this study is to determine the safety and tolerability, as well as to evaluate the anti-tumor efficacy and pharmacokinetics of NMS-03305293 in combination with TMZ.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Small Cell Lung Cancer

Intervention: DRUG: NMS-03305293

Route of administration: Oral

DRUG: Temozolomide

Route of administration: Oral Commercially available Temozolomid...